Skip to main content
Erschienen in: Rheumatology International 6/2012

01.06.2012 | Original Article

Predictive factors related to progression toward rheumatoid arthritis in Korean patients with undifferentiated arthritis

verfasst von: You Jung Ha, Yong-Beom Park, Myoung-Kyun Son, Sang-Youn Jung, Kwang-Hoon Lee, Soo-Kon Lee

Erschienen in: Rheumatology International | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Some patients with undifferentiated arthritis (UA) experience spontaneous remission; however, one-third of patients progress to rheumatoid arthritis (RA) in the final process of the disease. This study evaluated clinical variables in order to find a prediction model that could predict the development of RA in patients with UA. The medical records of 164 patients, who were initially diagnosed with undifferentiated arthritis in Yonsei University Medical Center from January 2004 to December 2007, were retrospectively reviewed. They were followed up for at least 6 months. The clinical variables related to the development of RA were identified by univariate analyses. Using logistic regression analysis, the prediction model was made and the diagnostic performance of the model was evaluated. Thirty-two patients of the 164 total patients progressed to RA during the follow-up period. The prediction model was composed of clinical factors including the duration of morning stiffness, the number of tender joints, the number of swollen joints, C-reactive protein level, rheumatoid factor, anti-cyclic citrullinated peptide antibody, and erosive change on baseline X-ray. The prediction score ranged from 0 to 10. All of the patients with a higher prediction score greater than five experienced RA progression. The area under the curve value for the prediction rule was 0.976. The prediction model could predict progression to RA in patients with UA. It especially helps the clinician to decide on a management plan for patients with a high prediction score.
Literatur
1.
Zurück zum Zitat Wolfe F, Ross K, Hawley DJ, Roberts FK, Cathey MA (1993) The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J Rheumatol 20:2005–2009PubMed Wolfe F, Ross K, Hawley DJ, Roberts FK, Cathey MA (1993) The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J Rheumatol 20:2005–2009PubMed
2.
Zurück zum Zitat van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JM (1998) Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 37:1084–1088PubMedCrossRef van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JM (1998) Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 37:1084–1088PubMedCrossRef
3.
Zurück zum Zitat Tunn EJ, Bacon PA (1993) Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 32:97–103PubMedCrossRef Tunn EJ, Bacon PA (1993) Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 32:97–103PubMedCrossRef
4.
Zurück zum Zitat Harrison BJ, Symmons DP, Brennan P, Barrett EM, Silman AJ (1996) Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol 35:1096–1100PubMedCrossRef Harrison BJ, Symmons DP, Brennan P, Barrett EM, Silman AJ (1996) Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol 35:1096–1100PubMedCrossRef
5.
Zurück zum Zitat van Aken J, van Dongen H, le Cessie S, Allaart CF, Breedveld FC, Huizinga TW (2006) Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis 65:20–25PubMedCrossRef van Aken J, van Dongen H, le Cessie S, Allaart CF, Breedveld FC, Huizinga TW (2006) Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis 65:20–25PubMedCrossRef
6.
Zurück zum Zitat Verpoort KN, van Dongen H, Allaart CF, Toes RE, Breedveld FC, Huizinga TW (2004) Undifferentiated arthritis: disease course assessed in several inception cohorts. Clin Exp Rheumatol 22(Suppl 35):S12–S17PubMed Verpoort KN, van Dongen H, Allaart CF, Toes RE, Breedveld FC, Huizinga TW (2004) Undifferentiated arthritis: disease course assessed in several inception cohorts. Clin Exp Rheumatol 22(Suppl 35):S12–S17PubMed
7.
Zurück zum Zitat van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hulsmans HM et al (2007) Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 56:1424–1432PubMedCrossRef van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hulsmans HM et al (2007) Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 56:1424–1432PubMedCrossRef
8.
Zurück zum Zitat van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW (2007) A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 56:433–440PubMedCrossRef van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW (2007) A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 56:433–440PubMedCrossRef
9.
Zurück zum Zitat Yoon BY, Lee CH, Han SH, Lee YW (2004) Clinical characteristics and joint involvement of rheumatoid arthritis. J Korean Rheum Assoc 11:227–234 Yoon BY, Lee CH, Han SH, Lee YW (2004) Clinical characteristics and joint involvement of rheumatoid arthritis. J Korean Rheum Assoc 11:227–234
10.
Zurück zum Zitat Lee HS, Korman BD, Le JM, Kastner DL, Remmers EF, Gregersen PK, Bae SC (2009) Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum 60:364–371PubMedCrossRef Lee HS, Korman BD, Le JM, Kastner DL, Remmers EF, Gregersen PK, Bae SC (2009) Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum 60:364–371PubMedCrossRef
11.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
12.
Zurück zum Zitat Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357–365PubMedCrossRef Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357–365PubMedCrossRef
13.
Zurück zum Zitat Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741–2749PubMedCrossRef Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741–2749PubMedCrossRef
14.
Zurück zum Zitat van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50:709–715PubMedCrossRef van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50:709–715PubMedCrossRef
15.
Zurück zum Zitat Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA (2002) Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29:2074–2076PubMed Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA (2002) Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29:2074–2076PubMed
16.
Zurück zum Zitat Haugeberg G, Green MJ, Quinn MA, Marzo-Ortega H, Proudman S, Karim Z et al (2006) Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis 65:736–740PubMedCrossRef Haugeberg G, Green MJ, Quinn MA, Marzo-Ortega H, Proudman S, Karim Z et al (2006) Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis 65:736–740PubMedCrossRef
17.
Zurück zum Zitat Feitsma AL, Toes RE, Begovich AB, Chokkalingam AP, de Vries RR, Huizinga TW, van der Helm-van Mil AH (2007) Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients. Rheumatology (Oxford) 46:1092–1095CrossRef Feitsma AL, Toes RE, Begovich AB, Chokkalingam AP, de Vries RR, Huizinga TW, van der Helm-van Mil AH (2007) Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients. Rheumatology (Oxford) 46:1092–1095CrossRef
18.
Zurück zum Zitat Quinn MA, Green MJ, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ et al (2003) Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 48:3039–3045PubMedCrossRef Quinn MA, Green MJ, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ et al (2003) Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 48:3039–3045PubMedCrossRef
Metadaten
Titel
Predictive factors related to progression toward rheumatoid arthritis in Korean patients with undifferentiated arthritis
verfasst von
You Jung Ha
Yong-Beom Park
Myoung-Kyun Son
Sang-Youn Jung
Kwang-Hoon Lee
Soo-Kon Lee
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 6/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1806-1

Weitere Artikel der Ausgabe 6/2012

Rheumatology International 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.